Artificial pancreas are all set to hit the markets
Type I Diabetes patients can breathe a sigh of relief as reports from the backyards of scientists say that soon enough, artificial pancreas are about to hit the market soon enough.
A medical technology company developed the first device to combine an automated glucose monitor and an insulin pump. It administers an accurate amount of insulin as needed and will also automatically shut off insulin release when a drop in sugar levels is detected. This minimizes the risks of taking too much or too little insulin, both of which can have fatal consequences.
It is described as the first hybrid closed loop system in the world. The device only requires patients to input mealtime carbohydrates and calibrate the sensors periodically, allowing them to live life more freely. It also helps them sleep well through the night and wake up with healthy glucose levels.
This first-of-its-kind technology can provide people with type 1 Diabetes greater freedom to live their lives without having to consistently and manually monitor baseline glucose levels and administer insulin.
In type 1 diabetes, the pancreas does not produce insulin, so the body loses its ability to naturally control blood glucose. If untreated, the disease can cause blindness, prompt kidney failure, or heighten risks for cardiovascular disease, among other complications.
Currently, there is no cure for type 1 diabetes, but as medical technology advances, new hopes arise for people afflicted by this disease and so many others.